Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-08

Clinical Trial Update: Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer [NA]

View source ↗

Summary

A pharmacogenetic screening study of a coumarin-based oral anticoagulant using next-generation sequencing is listed, but phase and status are unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Warfarin (warfarin)

Snippet

Sponsor: Tanta University | Conditions: Thrombosis | NA | Status: UNKNOWN